| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 127.658 | 2.884.342 | 2.655.111 | 88.705 |
| Total Income - EUR | - | - | - | - | - | - | 127.680 | 2.890.344 | 2.684.723 | 90.264 |
| Total Expenses - EUR | - | - | - | - | - | - | 123.137 | 2.765.727 | 2.633.028 | 21.610 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 4.543 | 124.617 | 51.695 | 68.654 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 777 | 92.427 | 43.122 | 57.622 |
| Employees | - | - | - | - | - | - | 0 | 3 | 2 | 0 |
Check the financial reports for the company - Essential Tissue S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 33.549 | 8.336 | 0 |
| Current Assets | - | - | - | - | - | - | 216.103 | 362.994 | 387.145 | 1.095 |
| Inventories | - | - | - | - | - | - | 55.170 | 0 | 284 | 0 |
| Receivables | - | - | - | - | - | - | 39.164 | 333.090 | 386.643 | 937 |
| Cash | - | - | - | - | - | - | 121.769 | 29.904 | 218 | 158 |
| Shareholders Funds | - | - | - | - | - | - | 50.304 | 1.633 | -79.412 | -6.161 |
| Social Capital | - | - | - | - | - | - | 49.527 | 49.681 | 49.530 | 49.253 |
| Debts | - | - | - | - | - | - | 165.799 | 394.910 | 474.892 | 7.256 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Essential Tissue S.r.l.